Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

[1]  S. Scholl,et al.  First Report of a Prospective Randomised Controlled Trial of Recombinant Human Erythropoietin after Allogeneic Blood Stem Cell Transplantation. , 2004 .

[2]  C. Bokemeyer,et al.  EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. , 2004, European journal of cancer.

[3]  Allen R Nissenson,et al.  Pure red-cell aplasia and epoetin therapy. , 2004, The New England journal of medicine.

[4]  A. Gewirtz,et al.  Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. , 2004, Blood.

[5]  R. Bouabdallah,et al.  Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level , 2004, Transfusion.

[6]  D. Blaise,et al.  Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. , 2004, Blood.

[7]  Y. Brandberg,et al.  Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2003, Cancer.

[8]  B. Djulbegovic,et al.  Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[9]  F. Baron,et al.  Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation , 2002, Transplantation.

[10]  F. Baron,et al.  Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. , 2002, Experimental hematology.

[11]  R. Storb,et al.  Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. , 2001, Blood.

[12]  C. Kasper,et al.  Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies , 2001, Annals of Hematology.

[13]  H. Lazarus,et al.  Erythropoietin in stem cell transplantation , 2001, Bone Marrow Transplantation.

[14]  R. Storb,et al.  Non-myeloablative transplants for malignant disease. , 2001, Hematology. American Society of Hematology. Education Program.

[15]  J. Groopman,et al.  Chemotherapy-induced anemia in adults: incidence and treatment. , 1999, Journal of the National Cancer Institute.

[16]  H. Ludwig.  Epoetin in cancer-related anaemia. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[18]  E. Estey,et al.  Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. , 1997, Blood.

[19]  M. R. Ricciardi,et al.  Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. , 1997, Blood.

[20]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[21]  J. Szer,et al.  Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group. , 1995, Bone marrow transplantation.

[22]  F. Mandelli,et al.  A controlled trial of recombinant human erythropoietin after bone marrow transplantation. , 1994, Blood.

[23]  P. Ljungman,et al.  Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study. , 1994, Transplantation Proceedings.

[24]  G. Fillet,et al.  Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. , 1993, Bone marrow transplantation.

[25]  M. Otero,et al.  Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial. , 1992, Bone marrow transplantation.

[26]  S. Piantadosi,et al.  Impaired erythropoietin response to anemia after bone marrow transplantation. , 1992, Blood.

[27]  A. Bosi,et al.  Inadequate erythropoietin production in allogeneic bone marrow transplant patients. , 1991, Haematologica.

[28]  G. Fillet,et al.  Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants , 1991 .

[29]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.